Russell Hirsch Overview

  • Investor Type
  • Angel

  • Status
  • Active

  • Professionals
  • 1


  • Investments
  • 1

  • Exits
  • 1


Russell Hirsch General Information


Dr. Russell Hirsch serves as Managing Director at Prospect Venture Partners. He serves as Board Member at Chronic Care Management. Dr. Russell co-founded Prospect Venture Partners II and III, as dedicated life science funds with over $1 billion in capital under management. He served as a Board member at Topica Pharmaceuticals & Glooko. Prior to establishing Prospect Venture Partners II and III, Russell was a member of the Health Care Technology Group at Mayfield. He joined Mayfield in 1992, served as a Venture Partner from 1993 to 1994 and as a General Partner from 1995-2000. Russell played a key role in Mayfield's investment activities in the biotechnology and medical device sectors. As an Associate, he participated actively in the incubation of Millennium Pharmaceuticals (acquired by Takeda) and as a General Partner he was responsible for the incubation of Intuitive Surgical Devices (NASDAQ:ISRG). Prior to Mayfield, Russell was at the University of California San Francisco from 1984-1992 where he was engaged in biomedical research. His work, published in a variety of respected journals, focused on important aspects of hepatitis B viral replication. His descriptions of the reverse transcription and packaging functions of polymerase gene products merited publication in Nature. Russell serves or has served on the Board of Directors of Intuitive Surgical (NASDAQ: ISRG), Hansen Medical (NASDAQ: HNSN), Opus Medical (NASDAQ: ARTC), Orquest (NASDAQ: JNJ), AVEO Pharmaceuticals (NASDAQ: AVEO), Visiogen (NYSE: ABT acquired), Baxano, DFine, SentreHEART, Portola Pharmaceuticals and several other privately-held companies. Russell served as the Vice Chairman of the BOD of Interplast and on the Genetics Advisory Council of the Harvard Medical School-Partners Healthcare Center for Genetics and Genomics. Russell holds an M.D. and Ph.D. in Biochemistry from the University of California, San Francisco and a B.A. in Chemistry from the University of Chicago. He served as Board Member at NinePoint Medical.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Corporate Office
  • United States

Russell Hirsch Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Glooko 09-Nov-2010 0000 00000 000 Medical Records Systems Generating Revenue 0000000 000000 00.0

Russell Hirsch Exits (1)

Company Name Exit Date Exit Type Exit Size
Glooko 01-Jul-2022 000000000 00000000

Russell Hirsch Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Russell Hirsch Team (1)

Name Title Deals Funds Boards Office
Russell Hirsch Ph.D Angel Investor 00 0 0

Russell Hirsch FAQs

  • Who is Russell Hirsch?

    Russell Hirsch is an angel Investor who has made 1 investment.

  • What kind of investor is Russell Hirsch?

    Russell Hirsch is an angel investor.

  • What does Russell Hirsch do?

    As an angel investor, Russell Hirsch invests personal money into promising companies, typically in exchange for equity.

  • How many board seats does Russell Hirsch hold?

    Russell Hirsch holds a board seat in Cosán.

  • What has Russell Hirsch invested in?

    Russell Hirsch has invested in Glooko within the Medical Records Systems industry.

  • What has Russell Hirsch invested in recently?

    Russell Hirsch's latest investment was on 09-Nov-2010 in Glooko, a company within the Medical Records Systems industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »